Bristol-Myers Squibb Co (NYSE:BMY)

67.67
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
47.34
Today|||52-Week Range
69.86
+14.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$110.9B

Company Description

Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from biological processes called biologics. The company's biopharmaceutical research and development efforts in the affective (psychiatric) disorders, Alzheimer's/dementia, cardiovascular, diabetes, hepatitis, HIV/Acquired Immunodeficiency Syndrome (AIDS), oncology, immunologic disorders and fibrotic disease areas. Bristol-Myers Squibb was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol-Myers Squibb Co.
345 Park Avenue
New York New York 10154
P:(212) 546-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders40.56%
Other institutional32.82%
Individual stakeholders0.32%

Top Executives

Giovanni CaforioChief Executive Officer & Director
Charles A. BancroftChief Financial Officer & Executive Vice President
Paul von AutenriedChief Information Officer & Senior Vice President
Francis M. CussChief Scientific Officer & Executive VP
Anne N. NielsenChief Compliance & Ethics Officer

To view my watchlist

Not a member yet?

Sign up now for a free account